share_log

双鹭药业(002038.SZ):三款产品拟中标全国药品集中采购

Shuanglu Pharmaceutical (002038.SZ): Three products plan to win the bid for centralized national drug procurement

Zhitong Finance ·  Nov 6, 2023 22:53

Shuanglu Pharmaceutical (002038.SZ) issued an announcement. The company participated in the joint procurement office on November 6, 2023...

According to the Zhitong Finance App, Shuanglu Pharmaceutical (002038.SZ) issued an announcement. On November 6, 2023, the company participated in the bidding process for the ninth batch of centralized national drug procurement organized by the Joint Procurement Office (“Joint Procurement Office”). The company's products lenalidomide capsules (Lisheng), voglabose tablets (Lishengtai), and celodoxine capsules (Lishengyu) will win the bid in this centralized procurement. The proposed bid prices are: 286.66 yuan, 4.86 yuan, and 8.63 yuan, respectively.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment